Gates Funded Research Into Genetically Engineered Cattle Ticks
#1
Bill Gates Funded Research Into Genetically Engineered Cattle Ticks
450,000 Americans Have Red Meat Allergies From ‘Alpha-Gal Syndrome’ Caused by Tick Bites


July 28, 2023 [not all hyperlinks included below from the original]

As alpha-gal syndrome (AGS), a tick-borne disease that triggers an allergic reaction to red meat, sees a steep rise in cases, eyebrows are being raised over a coincidental alignment with research funded by the Bill & Melinda Gates Foundation.

AGS, first reported in Virginia in 2008, has seen an alarming increase over the past few years. According to a recent press release from the U.S. Centers for Disease Control and Prevention (CDC), an estimated 450,000 people in the U.S. have tested positive for alpha-gal since 2010.

In 2021, the number of positive test results for AGS surged by 41.3% compared to 2017, and testing for alpha-gal peaked at 66,106 persons that year.

The same year, The Bill & Melinda Gates Foundation announced a significant grant of $1,469,352 toward research into the Rhipicephalus microplus (“Asian blue”) tick. This tick is known to cause AGS, as verified by a publication in the ImmunoTargets and Therapy journal found in the U.S. National Library of Medicine (NLM).

The grant was channeled to Oxitec Ltd., a biotechnology company that genetically modified male ticks to carry a “self-limiting gene,” intending to control the tick population by releasing these engineered ticks to mate with wild females in high-infestation areas. Oxitec’s project purportedly aimed to address the global pest problem affecting cattle, a significant source of red meat.

In June 2023, after Oxitec reported high efficacy in its tick experimentation, the Gates Foundation provided an additional $4.8 million in funding.

However, the intertwining of Gates’s interests and this rise in AGS cases is drawing scrutiny. Gates holds stakes in pharmaceutical companies like Pfizer Inc. that produce antibiotics such as doxycycline, commonly used to treat tick-borne illnesses like Lyme disease. Moreover, in 2017, his foundation granted over $1 million to Ceres Nanosciences, a diagnostics company specializing in Lyme disease detection.

In the food industry, Gates has significant investments in plant-based and lab-grown meat companies. He has backed companies such as Upside Foods, Good Meat, Beyond Meat, and Impossible Foods, some of which which have been approved by the U.S. Department of Agriculture for the production and sale of meat substitute products.

While there is no definitive evidence linking Gates’s funding of tick research to the rise in AGS cases, the timing and the complexity of his interests have led to a growing call for more transparency and accountability.

But this isn’t the first time that Gates’s involvement in disease research and prevention has caused controversy. A similar series of events unfolded when Gates focused on malaria, a disease eradicated in the United States for decades, until recent developments.

Malaria was last detected in the U.S. back in 2003 when seven people in Palm Beach County were infected, as per the CDC. Fast forward to 2007, the Bill & Melinda Gates Foundation turned its sights on malaria research, subsequently pumping hundreds of millions of dollars into the cause, and increasing their malaria budget by 30% in 2014.

In a significant development, in July 2018, GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) launched Krintafel (tafenoquine), a new treatment for Plasmodium vivax malaria. This marked the first new treatment for the disease in over six decades. Gates Foundation funding was pivotal in the drug’s development, a fact corroborated by Forbes. The Foundation continued to invest in tafenoquine research, backing various studies, including a Lancet-published article praising the drug’s performance.

Meanwhile, in 2019, the Foundation backed the “Injectable Artesunate Assessment Report,” establishing the efficacy of injectable artesunate, a malaria vaccine.

Notably, in September 2020, the Gates Foundation granted over $1.3 million to Oxitec Ltd., the same company involved in the aforementioned genetically engineered tick research, for “mosquito field trials.” These trials involved the release of genetically engineered Aedes aegypti mosquitoes, known vectors of diseases including malaria, into Florida and Texas following EPA approval in March 2022.

This move sparked outrage from locals who voiced concerns about being turned into “guinea pigs” for this “criminal” experiment, according to Florida resident Meagan Hull. Councilman Mark Gregg likened the GMO mosquitoes to “Frankenstein bugs.”

Fast forward to March 2023, and FFF Enterprises, a specialty vaccine distributor, announced it would start stocking the Gates-backed artesunate vaccine. Three months later, in June 2023, the CDC issued an alert about locally acquired malaria cases in Florida and Texas. Interestingly, the CDC, funded by the Gates Foundation, recommended rapid access to the artesunate vaccine.

As these series of events involving alpha-gal syndrome and malaria unfold, parallels can be drawn in the timing of the Gates Foundation’s funding and subsequent disease outbreaks. Though direct causality hasn’t been established, the correlation has led to calls for more in-depth investigations and heightened accountability. Transparency about these ties is paramount to alleviate public concerns and ensure ethical practices in disease prevention and treatment.
"So let us be confident, let us not be unprepared, let us not be outflanked, let us be wise, vigilant, fighting against those who are trying to tear the faith out of our souls and morality out of our hearts, so that we may remain Catholics, remain united to the Blessed Virgin Mary, remain united to the Roman Catholic Church, remain faithful children of the Church."- Abp. Lefebvre
Reply
#2
Bioethicist Suggests Re-Engineering Humans To Become Allergic To Meat

wibc.com | June 23, 2021


This is one of those rare moments where we don’t know if we should make jokes or fear for our lives. Prepare yourself.

A viral video shows a bioethicist suggest we re-engineer humans to become allergic to meat in order to control climate change.

A video of a panel at the 2016 World Science Festival has resurfaced causing outrage from thousands on social media. S. Matthew Liao is speaking about reducing humanity’s footprint on the planet.

Liao says a major impact each of us can make is by limiting our meat. He then brings up the idea of altering one’s body to be allergic to all meat in order to help with our over consumption. An example is given of how a tick bite can cause alpha-gal allergy (red meat allergy.)

“There’s this thing called the lone star tick where if it bites you, you will become allergic to meat…That’s something we can do through human engineering. We can kind of possibly address really big world problems through human engineering.”


Tony Katz says this is a bigger conversation than just ‘the woke is after our steak.’

“This is about people deciding that other people are imperfect and let us do things to make them better…The fact that one human being could think they have the ability to, the right to, or they are somehow ordained to change another.”

In the video Liao did not suggest we use a tick bite to alter our bodies, but rather said it was possible. Katz says he’s actually glad this was brought to light as it’s something we need to be aware of.

“There’s no way to look at this other than to say this is the ugliest concept. I’m glad it was brought up so we can note that it is ugly. But you will find people who approve of this and in that you will find the totalitarian.”
"So let us be confident, let us not be unprepared, let us not be outflanked, let us be wise, vigilant, fighting against those who are trying to tear the faith out of our souls and morality out of our hearts, so that we may remain Catholics, remain united to the Blessed Virgin Mary, remain united to the Roman Catholic Church, remain faithful children of the Church."- Abp. Lefebvre
Reply


Forum Jump:


Users browsing this thread: 3 Guest(s)